Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
暂无分享,去创建一个
J. Dunn | N. Nathoo | James A. Rogers | V. Wee Yong | T. Johnson | Ying Wu
[1] Xavier Golay,et al. Cause and prevention of demyelination in a model multiple sclerosis lesion , 2016, Annals of neurology.
[2] Runze Yang,et al. Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method , 2015, Scientific Reports.
[3] B. Trapp,et al. Pathological mechanisms in progressive multiple sclerosis , 2015, The Lancet Neurology.
[4] B. Trapp,et al. Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis , 2015 .
[5] Ricarda Diem,et al. Neurological deficits caused by tissue hypoxia in neuroinflammatory disease , 2013, Annals of neurology.
[6] J. Dunn,et al. Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination , 2013, Multiple sclerosis.
[7] Ondrej Dolezal,et al. Clinical correlates of grey matter pathology in multiple sclerosis , 2012, BMC Neurology.
[8] Allan MacKenzie-Graham,et al. Cortical atrophy in experimental autoimmune encephalomyelitis: In vivo imaging , 2012, NeuroImage.
[9] R. Reynolds,et al. Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis , 2012, Multiple sclerosis.
[10] Henry Rusinek,et al. Characterizing Brain Oxygen Metabolism in Patients with Multiple Sclerosis with T2-Relaxation-Under-Spin-Tagging MRI , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] V. Yong,et al. A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis , 2012, Journal of Neuroinflammation.
[12] P. Matthews,et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability , 2011, Multiple sclerosis.
[13] M. Calabrese,et al. The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.
[14] P. Fagenholz,et al. Hypoxia and inflammation. , 2011, The New England journal of medicine.
[15] Jeff F. Dunn,et al. A method for measuring brain partial pressure of oxygen in unanesthetized unrestrained subjects: The effect of acute and chronic hypoxia on brain tissue PO2 , 2010, Journal of Neuroscience Methods.
[16] Arthur W. Toga,et al. Purkinje cell loss in experimental autoimmune encephalomyelitis , 2009, NeuroImage.
[17] M. Karin,et al. Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.
[18] R. Rudick,et al. Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.
[19] David H. Miller,et al. Gray matter atrophy is related to long‐term disability in multiple sclerosis , 2008, Annals of neurology.
[20] W. Kaelin,et al. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.
[21] S. Rocha,et al. Regulation of hypoxia-inducible factor-1α by NF-κB , 2008, The Biochemical journal.
[22] A. Windebank,et al. Increased Expression of Endoplasmic Reticulum Stress-Related Signaling Pathway Molecules in Multiple Sclerosis Lesions , 2008, Journal of neuropathology and experimental neurology.
[23] G. Johnson,et al. Perfusion Magnetic Resonance Imaging Correlates of Neuropsychological Impairment in Multiple Sclerosis , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] C R G Guttmann,et al. Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.
[25] Marco Battaglini,et al. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.
[26] Glyn Johnson,et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. , 2007, Archives of neurology.
[27] P. Ratcliffe,et al. Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. , 2007, The Biochemical journal.
[28] J. Nielsen,et al. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity , 2006, Proceedings of the National Academy of Sciences.
[29] Arthur W. Toga,et al. Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis , 2006, NeuroImage.
[30] Jean-Marc Constans,et al. Reduced thalamic and cerebellar rest metabolism in relapsing–remitting multiple sclerosis, a positron emission tomography study: Correlations to lesion load , 2006, Journal of the Neurological Sciences.
[31] D. Pham‐Dinh,et al. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat , 2006, Experimental Neurology.
[32] D. Lübbers,et al. Behavior of microflow and localPO2 of the brain cortex during and after direct electrical stimulation , 1976, Pflügers Archiv.
[33] J. Nielsen,et al. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[34] G. Semenza,et al. Regulation of gene expression by HIF-1. , 2006, Novartis Foundation symposium.
[35] S. Shapiro,et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] J. W. Lindsey. EAE: History, Clinical Signs, and Disease Course , 2005 .
[37] H. Lassmann,et al. Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? , 2005, Acta Neuropathologica.
[38] R. Buxton,et al. Modeling the hemodynamic response to brain activation , 2004, NeuroImage.
[39] M R Symms,et al. Abnormalities of cerebral perfusion in multiple sclerosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[40] N. De Stefano,et al. Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.
[41] F. Aktan. iNOS-mediated nitric oxide production and its regulation. , 2004, Life sciences.
[42] David H. Miller,et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.
[43] R. Reynolds,et al. Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult , 2003, Brain pathology.
[44] K. Kivirikko,et al. Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor* , 2003, Journal of Biological Chemistry.
[45] R. Jaenisch,et al. HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.
[46] B. Brüne,et al. NO and TNF-α released from activated macrophages stabilize HIF-1α in resting tubular LLC-PK1 cells , 2003 .
[47] K. Jellinger,et al. Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases , 2003, Journal of neuropathology and experimental neurology.
[48] R. Jaenisch,et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. , 2003, Cell.
[49] B. Brüne,et al. NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells. , 2003, American journal of physiology. Cell physiology.
[50] J. Geng,et al. NF-kappaB activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells. , 2001, Biochemical and biophysical research communications.
[51] Michael I. Wilson,et al. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.
[52] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[53] G. Semenza. HIF-1 and mechanisms of hypoxia sensing. , 2001, Current opinion in cell biology.
[54] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[55] M. Blinkenberg,et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS , 2000, Neurology.
[56] J R Griffiths,et al. The OxyLite: a fibre-optic oxygen sensor. , 1999, The British journal of radiology.
[57] S. Kondo,et al. Clinical significance of reduced cerebral metabolism in multiple sclerosis: A combined PET and MRI study , 1998, Annals of nuclear medicine.
[58] F. Fazio,et al. Functional Basis of Memory Impairment in Multiple Sclerosis: A [18F]FDG PET Study , 1996, NeuroImage.
[59] G. Semenza,et al. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[60] C. W. Adams,et al. Perivascular iron deposition and other vascular damage in multiple sclerosis. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[61] J. Dunn. Metabolic adjustments to acute hypoxia in the African lungfish and rainbow trout , 1985 .
[62] J Marshall,et al. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. , 1984, Journal of neurology, neurosurgery, and psychiatry.
[63] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[64] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.